Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
18.56
-1.43 (-7.15%)
Mar 12, 2026, 1:27 PM EDT - Market open
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $3.06 billion as of March 12, 2026. Its market cap has increased by 122.12% in one year.
Market Cap
3.06B
Enterprise Value
2.27B
1-Year Change
122.12%
Ranking
Category
Stock Price
$18.56
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $3.06B, an increase of 287.27%. That is a compound annual growth rate of 28.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 3.30B | 2.43% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewAmsterdam Pharma Company | 3.60B |
| Corcept Therapeutics | 3.59B |
| Denali Therapeutics | 3.43B |
| Edgewise Therapeutics | 3.32B |
| Alumis | 3.28B |
| Spyre Therapeutics | 3.26B |
| Arcus Biosciences | 3.06B |
| Vera Therapeutics | 3.00B |